SCHEMBL4391286

SCHEMBL4391286

CC(C)(C)OC(=O)NC1CCNCC1.Cn1nnnc1N1CCC(NC(=O)O)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CKS1B P61024 1/20 0.42
▸ SKP1 P63208 1/20 0.42
▸ SKP2 Q13309 1/20 0.42
▸ HPGDS O60760 3/20 0.41
▸ KCNA3 P22001 1/20 0.41
▸ PDE10A Q9Y233 1/20 0.38
▸ CTSK P43235 2/20 0.38
▸ PARP1 P09874 1/20 0.37
▸ KDM4D Q6B0I6 1/20 0.36
▸ JAK2 O60674 1/20 0.36
▸ JAK1 P23458 1/20 0.36
▸ TYK2 P29597 1/20 0.36
▸ JAK3 P52333 1/20 0.36
▸ CCR5 P51681 1/20 0.35
▸ PIM1 P11309 1/20 0.35
▸ PIM3 Q86V86 1/20 0.35
▸ PIM2 Q9P1W9 1/20 0.35
▸ OPRM1 P35372 1/20 0.35
▸ OPRD1 P41143 1/20 0.35
▸ OPRK1 P41145 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19020818 0.89 HPGDS (0.48) CKS1BSKP1SKP2HPGDSKCNA3
SCHEMBL4394130 0.82 HPGDS (0.50) HPGDSGAA
SCHEMBL5185499 0.77 MEN1 (0.53) CKS1BSKP1SKP2KCNA3PDE10A
SCHEMBL56856 0.73 EPHX1 (0.53) KCNA3CTSKBTKGAA
Ammonia Solution, Strong SCHEMBL15021680 0.72 EPHX1 (0.52) KCNA3CTSKBTKDRD2GAA
Hydrochloric Acid SCHEMBL4158527 0.72 EPHX1 (0.52) KCNA3CTSKBTKDRD2GAA
Water SCHEMBL27795194 0.72 EPHX1 (0.52) KCNA3CTSKBTKDRD2GAA
SCHEMBL4715249 0.70 CTSK (0.51) CKS1BSKP1SKP2KCNA3CTSK
SCHEMBL21789373 0.70 JAK1 (0.47) CKS1BSKP1SKP2KCNA3CTSK
SCHEMBL28544121 0.70 JAK1 (0.47) CKS1BSKP1SKP2KCNA3CTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2129660-A2 NICOTINAMIDE DERIVATIVES AS INHIBITORS OF H-PGDS AND THEIR USE FOR TREATING PROSTAGLANDIN D2 MEDIATED DISEASES Pfizer Products Inc. (US) 2009-12-09 — — EP disclosed
WO-2008075172-A2 NICOTINAMIDE DERIVATIVES AS INHIBITORS OF H-PGDS AND THEIR USE FOR TREATING PROSTAGLANDIN D2 MEDIATED DISEASES PFIZER PRODUCTS INC. (US) 2008-06-26 — — WO disclosed
Send feedback